On September 6, 2005, the Federal Trade Commission (FTC) released a long awaited study of potential conflicts of interest by independent pharmacy benefit managers (PBMs). Like any good study of alleged wrongdoing, the FTC examined both motive and performance.The FTC's analysis indicated that it...